Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.

Brooks JD, Boice JD Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, Bernstein JL, Shore RE; WECARE Collaborative Group.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):917-24. doi: 10.1016/j.ijrobp.2012.01.047. Epub 2012 Apr 6.

2.

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group.

J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. doi: 10.1093/jnci/djq055. Epub 2010 Mar 19.

3.

Reproductive history and risk of second primary breast cancer: the WECARE study.

Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):906-11.

4.

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group.

Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.

5.

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.

Gao X, Fisher SG, Emami B.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1038-45.

PMID:
12829139
6.

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.

Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M; WECARE Study Collaborative Group, Bernstein JL.

Cancer Med. 2016 Nov;5(11):3282-3291. doi: 10.1002/cam4.890. Epub 2016 Oct 3.

7.

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.

Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL; Women's Environmental, Cancer, and Radiation Epidemiology Study Collaborative Group.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1021-30. doi: 10.1016/j.ijrobp.2008.02.040. Epub 2008 Jun 14.

8.

Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.

Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS, Woods M, Liang X, Bernstein JL; WECARE Study Collaborative Group.

Int J Cancer. 2017 Sep 1;141(5):916-924. doi: 10.1002/ijc.30791. Epub 2017 May 31.

PMID:
28524234
9.

Adjuvant radiotherapy and risk of contralateral breast cancer.

Storm HH, Andersson M, Boice JD Jr, Blettner M, Stovall M, Mouridsen HT, Dombernowsky P, Rose C, Jacobsen A, Pedersen M.

J Natl Cancer Inst. 1992 Aug 19;84(16):1245-50.

PMID:
1640483
10.

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group, Haile RW, Concannon P, Bernstein JL.

Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29.

11.

Body mass index and risk of second primary breast cancer: the WECARE Study.

Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; WECARE Study Collaborative Group, Bernstein JL, Bernstein L.

Breast Cancer Res Treat. 2012 Jan;131(2):571-80. doi: 10.1007/s10549-011-1743-4. Epub 2011 Sep 3.

12.

Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.

Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM; WECARE Study Collaborative Group.

Springerplus. 2015 Dec 30;4:825. doi: 10.1186/s40064-015-1642-y. eCollection 2015.

13.

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.

Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL.

J Clin Oncol. 2013 Feb 1;31(4):433-9. doi: 10.1200/JCO.2012.43.2013. Epub 2012 Dec 26.

14.

Risk factors for contralateral breast cancer in Chennai (Madras), India.

Gajalakshmi CK, Shanta V, Hakama M.

Int J Epidemiol. 1998 Oct;27(5):743-50.

PMID:
9839728
15.

Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.

Neta G, Anderson WF, Gilbert E, Berrington A.

Breast Cancer Res Treat. 2012 Feb;131(3):1021-7. doi: 10.1007/s10549-011-1820-8. Epub 2011 Oct 21.

16.

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.

Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods M, Concannon PJ; WECARE Study Collaborative Group, Bernstein JL.

Breast Cancer Res. 2016 Jul 12;18(1):65. doi: 10.1186/s13058-016-0726-0.

17.

Quantification of contralateral breast dose and risk estimate of radiation-induced contralateral breast cancer among young women using tangential fields and different modes of breathing.

Zurl B, Stranzl H, Winkler P, Kapp KS.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):500-5. doi: 10.1016/j.ijrobp.2012.04.016. Epub 2012 May 26.

PMID:
22633190
18.

Lung cancer risk and radiation dose among women treated for breast cancer.

Inskip PD, Stovall M, Flannery JT.

J Natl Cancer Inst. 1994 Jul 6;86(13):983-8.

PMID:
8007020
19.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.

PMID:
12837833
20.

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.

Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, Liang X, Morrow M, Bernstein JL; WECARE Study Collaborative Group.

Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x.

Supplemental Content

Support Center